Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 4:22 pm | N/A 2034-01-02 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 35,000 | $0 | 122,575 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:22 pm | N/A 2034-01-02 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 52,575 | $1.32 | 122,575 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:14 pm | N/A 2033-01-03 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 40,500 | $1.67 | 110,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:14 pm | N/A 2033-01-03 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 35,000 | $0 | 110,500 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:05 pm | N/A 2032-01-03 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 25,000 | $0 | 97,872 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:05 pm | N/A 2032-01-03 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 47,872 | $1.13 | 97,872 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 5:55 pm | 2021-12-31 2031-02-19 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 25,000 | $0 | 238,340 (Direct) | View |
Ownership | 2020-09-18 4:14 pm | N/A 2030-07-13 | Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director | 0 | $0 | 213,340 (Direct) | View |